Comparative effectiveness of immune-checkpoint inhibitors for previously treated advanced non-small cell lung cancer – A systematic review and network meta-analysis of 3024 participants-Reference-Cited by-同舟云学术

Comparative effectiveness of immune-checkpoint inhibitors for previously treated advanced non-small cell lung cancer – A systematic review and network meta-analysis of 3024 participants

Published:2018-01 Issue: Volume:115 Page:84-88
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Tan Pui San,Aguiar Pedro,Haaland Benjamin,Lopes Gilberto

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference19 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int. J. Cancer,2015

2. Global cancer statistics, 2002;Parkin;CA. Cancer J. Clin.,2005

3. Cancer statistics, 2016;Siegel;CA. Cancer J. Clin.,2016

4. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N. Engl. J. Med.,2002

5. PointBreak: a randomized phase III study of pemetrexed plus carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab versus paclitaxel plus carboplatin and bevacizumab followed by maintenance bevacizumab in patients with stage IIIB o;Patel;J. Clin. Oncol.,2013

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and financial impact of immune checkpoint inhibitors following platinum chemotherapy in patients with advanced or metastatic non-small cell lung cancer: a nationwide population-based study;Translational Lung Cancer Research;2024-01

2. Deciphering pathogenic cellular module at single-cell resolution in checkpoint inhibitor-related pneumonitis;Oncogene;2023-08-31

3. A Risk-Scoring Model for Severe Checkpoint Inhibitor-Related Pneumonitis: A Case–Control Study;Clinical Drug Investigation;2023-04-25

4. Successful management of Epstein‑Barr virus‑associated severe checkpoint inhibitor‑related pneumonitis: A case report;Experimental and Therapeutic Medicine;2023-03-29

5. Characterization of heterogeneous metabolism in hepatocellular carcinoma identifies new therapeutic target and treatment strategy;Frontiers in Immunology;2023-03-16